These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31080742)

  • 1. Metabolic dysfunction in Emirati subjects in Abu Dhabi: Relationship to levels of soluble RAGEs.
    Abdulle A; Inman CK; Saleh A; Noshi M; Galani D; Abdelwareth L; Alsafar H; Elfatih A; Al Shamsi H; Ali R; Li H; Ramasamy R; Schmidt AM; Benbarka MM; Hassan MH
    J Clin Transl Endocrinol; 2019 Jun; 16():100192. PubMed ID: 31080742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AGE-RAGE axis in an Arab population: The United Arab Emirates Healthy Futures (UAEHFS) pilot study.
    Inman CK; Aljunaibi A; Koh H; Abdulle A; Ali R; Alnaeemi A; Al Zaabi E; Oumeziane N; Al Bastaki M; Al-Houqani M; Al-Maskari F; Al Dhaheri A; Shah SM; Abdel Wareth L; Al Mahmeed W; Alsafar H; Al Anouti F; Al Hosani A; Haji M; Galani D; O'Connor MJ; Ahn J; Kirchhoff T; Sherman S; Hayes RB; Li H; Ramasamy R; Schmidt AM
    J Clin Transl Endocrinol; 2017 Dec; 10():1-8. PubMed ID: 29204365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.
    Moriya S; Yamazaki M; Murakami H; Maruyama K; Uchiyama S
    J Stroke Cerebrovasc Dis; 2014; 23(10):2540-2546. PubMed ID: 25282185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes.
    Lee AC; Lam JK; Shiu SW; Wong Y; Betteridge DJ; Tan KC
    PLoS One; 2015; 10(9):e0137330. PubMed ID: 26325204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional Analysis of AGE-CML, sRAGE, and esRAGE with Diabetes and Cardiometabolic Risk Factors in a Community-Based Cohort.
    Loomis SJ; Chen Y; Sacks DB; Christenson ES; Christenson RH; Rebholz CM; Selvin E
    Clin Chem; 2017 May; 63(5):980-989. PubMed ID: 28280052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial differences in circulating levels of the soluble receptor for advanced glycation endproducts in middle-aged and older adults.
    Brinkley TE; Leng X; Nicklas BJ; Kritchevsky SB; Ding J; Kitzman DW; Hundley WG
    Metabolism; 2017 May; 70():98-106. PubMed ID: 28403949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between serum levels of endogenous secretory RAGE and blood pressure in male nondiabetic patients with obstructive sleep apnea.
    Cai W; Sun JF; Liu Y; Xu JX; Xiao JR; Duan XM; Liu JY; Zhang W
    J Hum Hypertens; 2015 Dec; 29(12):713-8. PubMed ID: 25994997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of insulin on the soluble receptor for advanced glycation end products (RAGE).
    Lam JK; Wang Y; Shiu SW; Wong Y; Betteridge DJ; Tan KC
    Diabet Med; 2013 Jun; 30(6):702-9. PubMed ID: 23432638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of soluble receptor for advanced glycation end products isoforms and advanced glycation end products in long-living individuals.
    Scavello F; Tedesco CC; Castiglione S; Maciag A; Sangalli E; Veglia F; Spinetti G; Puca AA; Raucci A
    Biomark Med; 2021 Aug; 15(11):785-796. PubMed ID: 34236256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.
    Tam XH; Shiu SW; Leng L; Bucala R; Betteridge DJ; Tan KC
    Clin Sci (Lond); 2011 Jan; 120(2):81-9. PubMed ID: 20726839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality.
    Prasad K
    Int J Angiol; 2014 Mar; 23(1):11-6. PubMed ID: 24627612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes.
    Humpert PM; Djuric Z; Kopf S; Rudofsky G; Morcos M; Nawroth PP; Bierhaus A
    Cardiovasc Diabetol; 2007 Mar; 6():9. PubMed ID: 17343760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients.
    Katakami N; Matsuhisa M; Kaneto H; Matsuoka TA; Sakamoto K; Yasuda T; Yamasaki Y
    Diab Vasc Dis Res; 2008 Sep; 5(3):190-7. PubMed ID: 18777492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total soluble and endogenous secretory receptor for advanced glycation endproducts (RAGE) in IBD.
    Meijer B; Hoskin T; Ashcroft A; Burgess L; Keenan JI; Falvey J; Gearry RB; Day AS
    J Crohns Colitis; 2014 Jun; 8(6):513-20. PubMed ID: 24291021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial.
    Colhoun HM; Betteridge DJ; Durrington P; Hitman G; Neil A; Livingstone S; Charlton-Menys V; Bao W; Demicco DA; Preston GM; Deshmukh H; Tan K; Fuller JH
    Diabetes; 2011 Sep; 60(9):2379-85. PubMed ID: 21771973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Endogenous Secretory Receptor for Advanced Glycation End-Products Levels Are Associated With Inflammation and Carotid Atherosclerosis in Prediabetes.
    Di Pino A; Urbano F; Zagami RM; Filippello A; Di Mauro S; Piro S; Purrello F; Rabuazzo AM
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1701-9. PubMed ID: 26885882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AGEs/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease.
    Prasad K; Dhar I; Zhou Q; Elmoselhi H; Shoker M; Shoker A
    Mol Cell Biochem; 2016 Dec; 423(1-2):105-114. PubMed ID: 27714575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced Glycation End Products and its Soluble Receptors in the Pathogenesis of Thoracic Aortic Aneurysm.
    Prasad K; Sarkar A; Zafar MA; Shoker A; Moselhi HE; Tranquilli M; Ziganshin BA; Elefteriades JA
    Aorta (Stamford); 2016 Feb; 4(1):1-10. PubMed ID: 27766267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of a disintegrin and metalloproteinase 10 in peripheral blood mononuclear cells in type 2 diabetes mellitus patients with the acute coronary syndrome: a pilot study.
    Ragavi R; Adole PS; Vinod KV; Pillai AA
    Endocrine; 2022 Sep; 77(3):461-468. PubMed ID: 35877008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
    Melin EO; Dereke J; Hillman M
    Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.